They found that endogenous IFN production is responsible for sustaining high levels of TRAIL, and that loss of IFN genes confers an adaptive advantage to cancer cells, since they confer resistance to IFNα-induced apoptosis (Sgorbissa et al. 2011). Here, IFNA17 is linked to cancer.